Investor profile for Lux Capital: typical check size, headquarters (888 7th Ave, New York, NY 10106), stages they lead or invest in, and links to website and social profiles. Part of the Venture Capital Tracker directory.

Lux Capital

New York–based firm investing in frontier science and deep tech — AI, biotech, defense, robotics, and space — often at contrarian, long-duration theses.

Typical check size

$1M-$10M (stage-based estimate)

Founded

2000

Headquarters

888 7th Ave, New York, NY 10106

AUM

N/A

Rounds they lead

Seed Series A

Rounds they invest

Pre-Seed Seed Series A Series B+

Portfolio companies we track

Startups in our directory that list Lux Capital as an investor (24 total).

Related investment articles

FAQs about Lux Capital

Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.

Lux Capital leads Seed and Series A rounds in our directory and also invests from pre-seed through Series B+. The firm is multi-stage within deep tech, with public portfolio examples spanning early science bets through growth.
Lux does not publish standard check sizes. For planning, see /lux-capital-check-size-2026 (~$1M–$10M stage-based estimate for seed/Series A leads). Our coverage notes approximately $4B+ AUM across vintages; treat any check-size figure as deal-specific unless Lux discloses it.
Lux is headquartered in New York City (888 7th Ave). The firm backs founders globally in deep tech — defense, biotech, and industrial categories are not NYC-limited.
Lux backs frontier technology where science and engineering outpace convention: AI/ML, biotech and drug discovery, defense and dual-use, robotics, space, materials, and quantum. Our directory tags deep-tech, ai-ml, and space-tech.
Lux commonly leads or co-leads early institutional rounds in its core deep-tech bets and follows winners with additional capital. Public examples include early positions in Anduril, Recursion, and Applied Intuition.
Linked startups include Hadrian (/startup/hadrian), Recursion (/startup/recursion), Runway ML (/startup/runway-ml), Applied Intuition (/startup/applied-intuition), Shapeways (/startup/shapeways), Thatch Health (/startup/thatch-health), and Maven (/startup/maven).
Use luxcapital.com and partner content (Josh Wolfe and Peter Hebert publish actively on thesis areas). Warm intros from technical founders, scientists, or co-investors in frontier categories work best; there is no public cold-email partner roster.
See our fund profile article 'Lux Capital: The NYC Firm Underwriting Frontier Science and Deep Tech at $4B AUM' (/nyc-lux-capital-deep-tech-frontier-science) for thesis, notable bets, and 2026 focus areas.